Quick Answer
Xenetic Biosciences, Inc. reported R&D Expense of $3.07 million for fiscal year 2025.
Xenetic Biosciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $3.07M | -6.8% |
| 2024 | $3.29M | -5.9% |
| 2023 | $3.49M | -26.7% |
| 2022 | $4.77M | +50.8% |
| 2021 | $3.16M | +82.7% |
| 2020 | $1.73M | -64.6% |
| 2019 | $4.89M | +69.5% |
| 2018 | $2.88M | -29.0% |
| 2017 | $4.06M | -90.7% |
| 2016 | $43.74M | +1173.7% |
| 2015 | $3.43M | -45.7% |
| 2014 | $6.32M | +105.2% |
| 2013 | $3.08M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $756.5K | +105.6% | +15.2% |
| June 30, 2025 | $656.6K | -29.7% | -25.3% |
| March 31, 2025 | $879.0K | -6.9% | +138.9% |
| September 30, 2024 | $368.0K | -63.9% | -60.6% |
| June 30, 2024 | $933.8K | +3.4% | -1.1% |
| March 31, 2024 | $944.3K | +58.6% | -7.5% |
| September 30, 2023 | $1.02M | +155.9% | +13.0% |
| June 30, 2023 | $903.2K | -56.5% | +51.7% |
- Xenetic Biosciences, Inc. showed a decrease of -6.8% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Xenetic Biosciences, Inc.’s r&d expense has declined by 0.5% (from $3.08 million to $3.07 million).
- The most recent figure is from Xenetic Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: